Disorders associated with acute rapid and severe bone loss (Q35606552)

9 August 2017

1 reference

title

Disorders associated with acute rapid and severe bone loss (English)

1 reference

9 August 2017

Solomon Epstein

1

1 reference

9 August 2017

Angela M Inzerillo

series ordinal

2

1 reference

9 August 2017

John Caminis

series ordinal

3

1 reference

9 August 2017

Mone Zaidi

series ordinal

4

1 reference

9 August 2017

1 December 2003

1 reference

Journal of Bone and Mineral Research

9 August 2017

1 reference

9 August 2017

18

1 reference

9 August 2017

2083-2094

1 reference

9 August 2017

12

1 reference

Alendronate prevents loss of bone density associated with discontinuation of hormone replacement therapy: a randomized controlled trial

9 August 2017

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Glucocorticoid activity, inactivity and the osteoblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Bone histomorphometry in glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Prevention and treatment of glucocorticoid-induced osteoporosis. A pathogenetic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Use of oral corticosteroids and risk of fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Rheumatoid arthritis, corticosteroid therapy and hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Effects of inhaled glucocorticoids on bone density in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Children and the risk of fractures caused by oral corticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Mechanisms of glucocorticoid action in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Glucocorticoid-induced osteoporosis: pathogenesis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Immunogold localization of beta 1-integrin in bone: effect of glucocorticoids and insulin-like growth factor I on integrins and osteocyte formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Reduction in transforming growth factor beta receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Cortisol-induced suppression of plasma testosterone in normal adult males

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Glucocorticoid inhibition of FSH-induced estrogen production in cultured rat granulosa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Evidence for decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Clinical review 151: The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Immunosuppressant use without bone loss--implications for bone loss after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Cyclophilin: a specific cytosolic binding protein for cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Molecular and functional evidence for calcineurin-A alpha and beta isoforms in the osteoclast: novel insights into cyclosporin A action on bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Rapid loss of vertebral mineral density after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Changes in bone mass early after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Increased risk of fracture in patients receiving solid organ transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Status of patients presently living 9 to 13 years after orthotopic heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Osteoporosis in lung transplantation candidates with end-stage pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Osteoporosis in patients undergoing lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

The contribution of renal transplantation to final adult height: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Reduction of Bone Mass in Women after Bone Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Canalicular fluid flow induced by bending of a long bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Tensegrity: the architectural basis of cellular mechanotransduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Osteoporosis and risk of fracture in men with spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Fracture rates and risk factors for fractures in patients with spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Supralesional and sublesional bone mineral density in spinal cord-injured patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Long-Term fracture risk following ischemic stroke: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Changes in muscle mass, fat mass, and bone mineral content in the legs after stroke: a 1 year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

21 January 2018

Fractures after stroke.

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Vitamin D deficiency and risk of hip fractures among disabled elderly stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Alfacalcidol and calcitriol in the prevention of bone loss after organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Protective effect of short-tem calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Effects of estrogen plus progestin on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Failure of estrogen plus progestin therapy for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Calcitonin and bisphosphonates treatment in bone loss after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Calcitonin, etidronate, and calcidiol treatment in bone loss after cardiac transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Treatment of osteopenia and osteoporosis after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Prevention of bone loss and fracture after lung transplantation: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Pamidronate and calcitriol trial for the prevention of early bone loss after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2083

10.1359/JBMR.2003.18.12.2083

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference